NRG Oncology recently reported the results from the radiotherapy randomization, which was the second step of their NRG-RTOG 0848 clinical study comparing adjuvant chemotherapy with or without chemoradiation for patients with ...
Jun 4, 2024
0
1
Extended prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy (177Lu-PSMA) beyond six cycles is an effective and well-tolerated treatment for metastatic castration-resistant prostate cancer patients, ...
Jun 4, 2024
0
0
A medication to treat chronic myeloid leukemia (CML) has shown its potential to become the new frontline therapy for people living with the life-threatening blood cancer.
Jun 4, 2024
0
1
A new research perspective titled "Bruton's tyrosine kinase inhibitor-related cardiotoxicity: The quest for predictive biomarkers and improved risk stratification" has been published in Oncotarget.
Jun 4, 2024
0
0
Researchers have revealed how a channel that controls cellular potassium levels causes metabolic rewiring in breast cancer cells, promoting tumor growth.
Jun 4, 2024
0
0
Studying combined data from the UK Biobank, a unique record of patient information from more than half a million Britons, could help make "groundbreaking discoveries" in the understanding and treatment of breast cancer, say ...
Jun 4, 2024
0
0
For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. A global team of researchers have announced clinical trial ...
Jun 4, 2024
0
0
Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.
Jun 4, 2024
0
0
A new study to be presented at the SLEEP 2024 annual meeting, held in Houston, Texas, June 1–5, is the first to find that episodic hypoxemia and hypoxic burden related to obstructive sleep apnea are associated with the ...
Jun 4, 2024
0
0
Prof. Liu Zhibo's team from Peking University (PKU)'s College of Chemistry and Molecular Engineering, along with collaborators, recently published a paper titled "Covalent targeted radioligands potentiate radionuclide therapy" ...
Jun 4, 2024
0
0
